Epidemiology

HAP is more common in patients in the intensive care unit, those who have recently had major surgery, and those who have been in hospital for a long time.[6] It is associated with high morbidity and mortality because these patients are usually critically ill and have multiple comorbidities or severe frailty.[7]

In England, at any time, 1.5% of hospital inpatients have a hospital-acquired respiratory infection. Of these patients, more than half have HAP. HAP is estimated to increase hospital stay by about 8 days and has a reported mortality rate that ranges between 30% and 70%.[3]

Risk factors

Pathogens that cause HAP, such as Acinetobacter baumannii, are transmitted to patients from healthcare workers' hands.

Mechanical ventilation is the most significant risk factor for HAP (ventilator-associated pneumonia is not covered in this topic).[19][20]

People at high risk of multidrug-resistant bacteria are at higher risk of HAP. This includes patients with symptoms or signs starting more than 5 days after hospital admission; a relevant comorbidity, such as severe lung disease or immunosuppression; recent use of a broad-spectrum antibiotic; colonisation with multidrug-resistant bacteria; and recent contact with health or social care settings before current admission.[7]

A prior episode of a large-volume aspiration is associated with an increased risk of nosocomial pneumonia.[19]

Use of acid-suppression medication is associated with 30% increased odds of developing HAP, with a statistically significant risk only for use of proton-pump inhibitors.[21]

HAP outside the intensive care unit is more prevalent in patients with depressed consciousness.[20]

HAP outside the intensive care unit is more prevalent in patients undergoing thoracic and upper abdominal surgery.[19][20]

Use of this content is subject to our disclaimer